Sunshine Guojian Pharmaceutical Hits Day High with 8.69% Surge

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. has experienced a significant surge in its stock price, gaining 8.69% on May 29, 2026. The stock reached an intraday high of CNY 66.90, showcasing its strong performance against the backdrop of a declining China Shanghai Composite, which fell by 0.73% on the same day. Over the past week, Sunshine Guojian has shown a 4.27% increase, while its year-to-date performance stands at 8.18%. The company has demonstrated impressive long-term growth, with a remarkable 245.34% increase over the last three years and a 215.26% rise over the past five years. Financial metrics indicate a robust operational foundation, highlighted by a return on equity (ROE) of 33.75% and a price-to-earnings (P/E) ratio of 12.00. The company has consistently reported positive results for the last ten consecutive quarters, with profits rising by 131.7% over the past year. Additionally, Sunshine Guojian maintains a high dividend yield of 0.18%, further solidifying its position in the pharmaceuticals and biotechnology sector.